|
|
 |
|
Viewing report
|
|
|
|
2011 U.S. Biological Product Manufacturing Industry Report
Barnes Reports, Jan 2011, Pages: 67
The U.S. Biological Product Manufacturing Industry report, published annually, contains timely and accurate industry statistics, forecasts and demographics. The report features 2011 current and 2012 forecast estimates on the size of the industry (sales, establishments, employment) nationally and for all 50 U.S. States and over 900 metro areas. New to the report this year are: financial ratios, number of firms and payroll estimates. The report also includes industry definition, 5-year historical trends on industry sales, establishments and employment, a breakdown of establishments, sales and employment by employee size of establishment (9 categories), and estimates on up to 10 sub-industries, including vaccines, serums, plasmas, antitoxins, toxiods, blood fractions and culture media.
Industry Definition and Related Industries
NAICS 325414: Biological Product Mfg.
This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic).
Related Industries
- Medicinal & Botancial Mfg.
- Medical Laboratories
- Medical & Surgical Hospitals
U.S. Census Categories
NAICS 325414: Biological Product Mfg. is
- 100% comparable to SIC 2836– Biological products, except diagnostic
Sub-Industries:
- Biological products, except diagnostic
- Blood derivatives
- Coagulation products
- Plasmas
- Serums
- Extracts
- Allergens, allergenic extracts
- Vaccines and other immunizing products
- Antitoxins
- Bacterial vaccines
- Vaccines
- Culture media
- Agar culture media
- Bacteriological media
- Toxins, viruses, and similar substances, including venom
Please note, this report offers statistical information only and does not include an analysis of the figures.
|
|
|
|
